	US 12,239,678 B2
	Yeast for the treatment of allergy
Trevor Archer, Floda (SE); and Tomas Lenz, Örebro (SE)
Assigned to MILMED UNICO AB, Stockholm (SE)
Appl. No. 17/766,959
Filed by MILMED UNICO AB, Stockholm (SE)
PCT Filed Oct. 7, 2020, PCT No. PCT/SE2020/050958 § 371(c)(1), (2) Date Apr. 6, 2022, PCT Pub. No. WO2021/071413, PCT Pub. Date Apr. 15, 2021.
Claims priority of application No. 1951142-7 (SE), filed on Oct. 7, 2019.
Prior Publication US 2024/0066083 A1, Feb. 29, 2024
Int. Cl. A61K 36/064 (2006.01); A61P 37/08 (2006.01); C12N 1/20 (2006.01); C12N 13/00 (2006.01); C12R 1/86 (2006.01); C12R 1/865 (2006.01)

CPC A61K 36/064 (2013.01) [A61P 37/08 (2018.01); C12N 1/20 (2013.01); C12N 13/00 (2013.01); C12R 2001/86 (2021.05); C12R 2001/865 (2021.05)]

19 Claims

1. A method of treatment and/or alleviation of allergy and/or symptoms caused by allergy, comprising administering to a subject in need thereof, a yeast cell, wherein the yeast cell has been treated with electromagnetic waves in the range of 1 GHz to 300 GHz, or said yeast cell has been grown from a yeast cell treated with electromagnetic waves in the range of 1 GHz to 300 GHz, thereby treating and/or alleviating allergy and/or symptoms caused by allergy in the subject.